Related Experiment Video
Updated: May 5, 2026
09:04
Discovery of New Intracellular Pathogens by Amoebal Coculture and Amoebal Enrichment Approaches
Published on: October 27, 2013
14.4K
Dientamoeba fragilis: An emerging pathogen.
Candela Menéndez Fernández-Miranda1, Jonathan Fernández-Suárez2, Alicia García Pérez3
1Servicio de Medicina Interna, Fundación Hospital de Avilés, Avilés, Spain.
Summary
Dientamoeba fragilis, a common intestinal protozoan, causes gastrointestinal issues but remains poorly understood. Paromomycin demonstrates higher cure rates compared to metronidazole for treating this infection.
Area of Science:
- Medical Parasitology
- Gastroenterology
- Infectious Diseases
Background:
- Dientamoeba fragilis is a prevalent protozoan in the gastrointestinal tract, causing varied symptoms like abdominal pain, diarrhea, and eosinophilia, with some individuals remaining asymptomatic.
- Despite its prevalence, significant questions persist regarding D. fragilis, including its morphologies, transmission, pathogenicity, and optimal treatment, contributing to ongoing controversy.
- Identified risk factors for D. fragilis infection include contact with children, rural living, and co-infection with Enterobius vermicularis.
Purpose of the Study:
- To review the current understanding of Dientamoeba fragilis, encompassing its clinical significance, diagnostic approaches, and therapeutic options.
- To address the controversies and knowledge gaps surrounding D. fragilis infection.
- To evaluate the efficacy of different treatment modalities for D. fragilis.
Main Methods:
- Review of existing literature and clinical data on Dientamoeba fragilis.
- Analysis of diagnostic techniques, focusing on the role of molecular methods.
- Comparison of treatment outcomes for metronidazole and paromomycin.
Main Results:
- Molecular diagnostic techniques, including commercial multi-diagnostic panels, are now considered the preferred methods for D. fragilis detection.
- Paromomycin has shown superior cure rates in treating Dientamoeba fragilis infections when compared to metronidazole.
- Despite advancements, questions regarding morphology, prevalence, transmission, and pathogenicity remain subjects of debate.
Conclusions:
- Molecular diagnostics represent a significant advancement in identifying Dientamoeba fragilis infections.
- Paromomycin is a more effective treatment option than metronidazole for D. fragilis.
- Further research is necessary to resolve the persistent controversies and fully elucidate the biology and clinical impact of D. fragilis.
Related Concept Videos
01:28Fungal Phylum Microsporidia
782
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
782
01:15Diversity of Protists I
2.3K
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
2.3K
01:27Diversity of Protists II
2.3K
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
2.3K
01:27Overview of Protists
3.3K
Protists are diverse eukaryotic microorganisms that lack the specialized tissues of plants and animals and the chitinous cell walls of fungi. Their early divergence within Eukarya resulted in structural, functional, and ecological diversity. They are classified into supergroups such as Archaeplastida, Excavata, Amoebozoa, Rhizaria, Alveolata, and Stramenopiles, determined through genetic analysis and structural similarities.Structural and Functional AdaptationsProtists have various adaptations...
3.3K
01:27Diversity of Protists IV
2.1K
Amoebozoa represent a diverse group of terrestrial and aquatic protists that utilize lobe-shaped pseudopodia for locomotion and feeding. This characteristic differentiates them from the Rhizaria, which possess threadlike pseudopodia. The primary classifications within Amoebozoa include gymnamoebas, entamoebas, and the plasmodial and cellular slime molds. Phylogenetic evidence indicates that Amoebozoa diverged from a lineage that ultimately gave rise to fungi and animals.Gymnamoebas and...
2.1K
01:18Bacterial Gastroenteritis
88
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
88